The World Health Organization (WHO) Regional Office for Africa, through the Expanded Special Project for the Elimination of Neglected Tropical Diseases (ESPEN), is making available new analytical tools in the NTD Data Portal allowing Neglected Tropical Diseases programmes and stakeholders to better track rollout and impact of interventions, and make data-driven decisions on strategies.
A dedicated data portal for NTD programmes
The consolidated repository hosts data shared by health ministries through the Joint Application Package reporting system and provides a detailed ongoing picture of the status of Neglected Tropical Diseases (NTDs) programmes targeting Preventive Chemotherapy NTDs (PC-NTDs). Information is linked at the implementation unit level and can be freely accessed, enabling better tracking of progress, supporting cross-disease coordination, and facilitating comprehensive forward planning. Through the portal, users can readily view, download and validated, reliable longitudinal data and maps for planning and reporting purposes.
“It’s vital that countries do more to combat the variety of Neglected Tropical Diseases that are sadly still so prevalent across so much of Africa, causing millions of citizens severe disabilities and sometimes their lives. Access to updated and more accurate data is vital for countries to implement strategic plans that can truly help to save more lives and eliminate NTDs,” said Dr Maria Rebollo Polo, ESPEN Team Leader at WHO Regional Office for Africa.
“We encourage Neglected Tropical Disease control programmes across Africa to use this innovative tool so that their activities and investments result in real impact and can be coordinated in the most efficient way, making the most of often scarce resources,” Dr Polo said.
New analytical tools for guiding NTD country programmes
Evidence-based decision making for Neglected Tropical Diseases helps drive progress. The ESPEN Data Portal has expanded to include a comprehensive suite of data dashboards designed to help Neglected Tropical Diseases programmes better track rollout and impact of interventions and make data-driven decisions on future strategies.
The new ESPEN Progress and Forecast dashboards allow users to explore key statistics and analytics, graphics and maps, at both sub-national and national level. They outline current endemicity and progress on mass drug administration (MDA) interventions to date for each of the PC-NTDs, together with future treatment and impact assessment needs over the next ten years. The dashboards have been purpose designed to support national programmes to readily access and use their data, make better-informed decisions, and distribute resources more efficiently. Disease-specific dashboards can be accessed through country pages – simply visit your country page, and select the disease you’re interested in.
Making better use of our data
To complement the existing suite of maps and datasets, WHO Regional Office for Africa has now developed interactive dashboards detailing both current progress and projections for the next 10 years at the level of implementation. Using historical data compiled under the ESPEN data repository, we have forecasted when MDA interventions will be needed, what type of MDA strategy should be implemented (considering co-endemicity), and when impact assessment should be conducted, to achieve the goals established by the new 2021-2030 Roadmap for the Elimination of Neglected Tropical Diseases. These resources can greatly support completion of both National Neglected Tropical Diseases Masterplans, and Annual Work Plans.
These are new tools and, as such, may still be improved based on the feedback received from data portal users. We hugely value feedback from Neglected Tropical Diseases country programmes and partners on these new resources, and the portal in general Please send us your questions, comments, and inputs on the new developments to espensupport@who.int
About ESPEN
ESPEN is a WHO project created in the spirit of a public-private partnership with the goal of accelerating the elimination of five PC-NTDs in Africa. Since its launch in May 2016, ESPEN works with domestic and international partners to leverage US$ 17.8 billion in drug donations from pharmaceutical companies to expand coverage and access to treatments, strengthen health systems and provide Universal health coverage of interventions against PC-NTDs in Africa until we reach final elimination of these devastating diseases.
Distributed by APO Group on behalf of WHO Regional Office for Africa.
© Press Release 2021
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
